{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:42:17Z","timestamp":1763545337110,"version":"3.38.0"},"reference-count":23,"publisher":"Pharmaceutical Society of Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,2,28]]},"DOI":"10.1248\/bpb.b24-00657","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T22:16:25Z","timestamp":1740694585000},"page":"184-187","source":"Crossref","is-referenced-by-count":1,"title":["Antipruritic Effects of Single Administration of Paroxetine on Acute and Chronic Itch"],"prefix":"10.1248","volume":"48","author":[{"given":"Kosuke","family":"Matsuda","sequence":"first","affiliation":[{"name":"Department of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930\u20130194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Ishisaka","sequence":"additional","affiliation":[{"name":"Department of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930\u20130194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Sawahata","sequence":"additional","affiliation":[{"name":"Department of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930\u20130194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Kume","sequence":"additional","affiliation":[{"name":"Department of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930\u20130194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Uta","sequence":"additional","affiliation":[{"name":"Department of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930\u20130194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"doi-asserted-by":"crossref","unstructured":"1) Savin JA. How should we define itching? <i>J. Am. Acad. Dermatol<\/i>., <b>39<\/b>, 268\u2013269 (1998).","key":"1","DOI":"10.1016\/S0190-9622(98)70087-8"},{"doi-asserted-by":"crossref","unstructured":"2) Zeidler C, Raap U, Witte F, St\u00e4nder S. Clinical aspects and management of chronic itch. <i>J. Allergy Clin. Immunol<\/i>., <b>152<\/b>, 1\u201310 (2023).","key":"2","DOI":"10.1016\/j.jaci.2023.04.018"},{"doi-asserted-by":"crossref","unstructured":"3) Yamamura K, Nakahara T. The dawn of a New Era in atopic dermatitis treatment. <i>J. Clin. Med<\/i>., <b>11<\/b>, 6145 (2022).","key":"3","DOI":"10.3390\/jcm11206145"},{"doi-asserted-by":"crossref","unstructured":"4) Fowler E, Yosipovitch G. Chronic itch management: therapies beyond those targeting the immune system. <i>Ann. Allergy Asthma Immunol<\/i>., <b>123<\/b>, 158\u2013165 (2019).","key":"4","DOI":"10.1016\/j.anai.2019.01.016"},{"doi-asserted-by":"crossref","unstructured":"5) Mack MR, Kim BS. The itch-scratch cycle: a neuroimmune perspective. <i>Trends Immunol<\/i>., <b>39<\/b>, 980\u2013991 (2018).","key":"5","DOI":"10.1016\/j.it.2018.10.001"},{"doi-asserted-by":"crossref","unstructured":"6) Sanders KM, Akiyama T. The vicious cycle of itch and anxiety. <i>Neurosci. Biobehav. Rev<\/i>., <b>87<\/b>, 17\u201326 (2018).","key":"6","DOI":"10.1016\/j.neubiorev.2018.01.009"},{"doi-asserted-by":"crossref","unstructured":"7) Sanders KM, Sakai K, Henry TD, Hashimoto T, Akiyama T. A subpopulation of amygdala neurons mediates the affective component of itch. <i>J. Neurosci<\/i>., <b>39<\/b>, 3345\u20133356 (2019).","key":"7","DOI":"10.1523\/JNEUROSCI.2759-18.2019"},{"doi-asserted-by":"crossref","unstructured":"8) Zheng J, Zhang XM, Tang W, Li Y, Wang P, Jin J, Luo Z, Fang S, Yang S, Wei Z, Song K, Huang Z, Wang Z, Zhu Z, Shi N, Xiao D, Yuan L, Shen H, Huang L, Li B. An insular cortical circuit required for itch sensation and aversion. <i>Curr. Biol<\/i>., <b>34<\/b>, 1453\u20131468.e6 (2024).","key":"8","DOI":"10.1016\/j.cub.2024.02.060"},{"doi-asserted-by":"crossref","unstructured":"9) Goodnick PJ, Goldstein BJ. Selective serotonin reuptake inhibitors in affective disorders--I. <i>Basic pharmacology. J. Psychopharmacol.,<\/i> 12, Supplement B, S5\u201320 (1998).","key":"9","DOI":"10.1177\/0269881198012003021"},{"unstructured":"10) Attia EA, Hassan AA. Uremic pruritus pathogenesis, revisited. <i>Arab J. Nephrol. Transplant<\/i>., <b>7<\/b>, 91\u201396 (2014).","key":"10"},{"doi-asserted-by":"crossref","unstructured":"11) Steinhoff M, Cevikbas F, Ikoma A, Berger TG. Pruritus: management algorithms and experimental therapies. <i>Semin. Cutan. Med. Surg<\/i>., <b>30<\/b>, 127\u2013137 (2011).","key":"11","DOI":"10.1016\/j.sder.2011.05.001"},{"unstructured":"12) De Vloo C, Nevens F. Cholestatic pruritus: an update. <i>Acta Gastroenterol. Belg<\/i>., <b>82<\/b>, 75\u201382 (2019).","key":"12"},{"doi-asserted-by":"crossref","unstructured":"13) Metz M, Grundmann S, St\u00e4nder S. Pruritus: an overview of current concepts. <i>Vet. Dermatol<\/i>., <b>22<\/b>, 121\u2013131 (2011).","key":"13","DOI":"10.1111\/j.1365-3164.2010.00945.x"},{"doi-asserted-by":"crossref","unstructured":"14) Matsuda K, Kitano Y, Sawahata M, Kume T, Uta D. Mirogabalin inhibits scratching behavior of spontaneous model mouse of atopic dermatitis. <i>Front. Pharmacol<\/i>., <b>15<\/b>, 1382281 (2024).","key":"14","DOI":"10.3389\/fphar.2024.1382281"},{"doi-asserted-by":"crossref","unstructured":"15) Misery L, Pierre O, Le Gall-Ianotto C, Lebonvallet N, Chernyshov PV, Le Garrec R, Talagas M. Basic mechanisms of itch. <i>J. Allergy Clin. Immunol<\/i>., <b>152<\/b>, 11\u201323 (2023).","key":"15","DOI":"10.1016\/j.jaci.2023.05.004"},{"doi-asserted-by":"crossref","unstructured":"16) Andoh T, Gotoh Y, Kuraishi Y. Milnacipran inhibits itch-related responses in mice through the enhancement of noradrenergic transmission in the spinal cord. <i>J. Pharmacol. Sci<\/i>., <b>123<\/b>, 199\u2013202 (2013).","key":"16","DOI":"10.1254\/jphs.13122SC"},{"doi-asserted-by":"crossref","unstructured":"17) Miyahara Y, Funahashi H, Naono-Nakayama R, Haruta-Tsukamoto A, Muroi C, Kogoh Y, Nishimori T, Ishida Y. Serotonin and noradrenaline modulate chronic itch processing in mice. <i>Eur. J. Pharmacol<\/i>., <b>15<\/b>, 173319 (2020).","key":"17","DOI":"10.1016\/j.ejphar.2020.173319"},{"doi-asserted-by":"crossref","unstructured":"18) Miyahara Y, Funahashi H, Haruta-Tsukamoto A, Kogoh Y, Kanemaru-Kawazoe A, Nishimori T, Ishida Y. Roles of 5-HT<sub>3<\/sub> and 5-HT<sub>7<\/sub> receptors in acute pruriceptive processing in mice. <i>Eur. J. Pharmacol<\/i>., <b>15<\/b>, 174513 (2021).","key":"18","DOI":"10.1016\/j.ejphar.2021.174513"},{"doi-asserted-by":"crossref","unstructured":"19) Miyahara Y, Funahashi H, Haruta-Tsukamoto A, Kogoh Y, Kanemaru-Kawazoe A, Hirano Y, Nishimori T, Ishida Y. Differential contribution of 5-HT<sub>4<\/sub>, 5-HT<sub>5<\/sub>, and 5-HT<sub>6<\/sub> receptors to acute pruriceptive processing induced by chloroquine and histamine in mice. <i>Biol. Pharm. Bull<\/i>., <b>46<\/b>, 1601\u20131608 (2023).","key":"19","DOI":"10.1248\/bpb.b23-00445"},{"doi-asserted-by":"crossref","unstructured":"20) Zhao ZQ, Liu XY, Jeffry J, et al. Descending control of itch transmission by the serotonergic system <i>via<\/i> 5-HT1A-facilitated GRP-GRPR signaling. <i>Neuron<\/i>, <b>19<\/b>, 821\u2013834 (2014).","key":"20","DOI":"10.1016\/j.neuron.2014.10.003"},{"doi-asserted-by":"crossref","unstructured":"21) Jiang J, Kuhara T, Ueki R, Zheng Y, Suto H, Ikeda S, Ogawa H. Inhibitory effects of paroxetine on the development of atopic dermatitis-like lesions in NC\/Nga mice. <i>J. Dermatol. Sci<\/i>., <b>47<\/b>, 244\u2013247 (2007).","key":"21","DOI":"10.1016\/j.jdermsci.2007.05.006"},{"unstructured":"22) Hashiro M. Psychopharmacological therapy in dermatology. <i>Jpn. J. Psychosom. Med<\/i>., <b>57<\/b>, 1237\u20131244 (2017).","key":"22"},{"doi-asserted-by":"crossref","unstructured":"23) Bourin M, Chue P, Guillon Y. Paroxetine: a review. <i>CNS Drug Rev<\/i>., <b>7<\/b>, 25\u201347 (2001).","key":"23","DOI":"10.1111\/j.1527-3458.2001.tb00189.x"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/2\/48_b24-00657\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T03:31:36Z","timestamp":1740799896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/2\/48_b24-00657\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b24-00657","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"type":"print","value":"0918-6158"},{"type":"electronic","value":"1347-5215"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"article-number":"b24-00657"}}